ReNerve’s NervAlign gives post-op pain relief
ReNerve’s NervAlign Nerve Cuff shown to reduce post-op pain in foot and ankle peripheral nerve-repair surgeries
ReNerve’s NervAlign Nerve Cuff shown to reduce post-op pain in foot and ankle peripheral nerve-repair surgeries
As global share markets wobble, Australian investors are turning to real estate for security and growth. Reventon looks at the top suburbs it thinks will surge in 2025 and beyond.
Bellevue Gold has extended a suspension which could end in another negative production downgrade for the relatively new WA producer.
The ASX 200 has bounced back so far on Friday despite Wall Street ticking lower. Ressie and energy stocks are showing the way.
Uranium miner Boss is the most shorted stock on the ASX. But broker Euroz has initiated with a hefty price target.
Coolabah Metals takes a 70% interest in a Broken Hill joint venture and opens a new silver-lead-zinc source for its Rasp mine.
Helix Resources is making moves to acquire the White Hills project in Arizona hoping to find the next big copper and gold discovery.
Alice Queen’s drilling at Viani in Fiji has revealed encouraging gold results, setting AQX up well for the rest of the campaign.
Compumedics has received an order from Hangzhou Normal University (HZNU) in China for its Neuroscan Orion LifeSpan MEG system to map brain activity.
Projects such as Victory Metals’ North Stanmore could ease the squeeze if China restricts terbium exports.
Despite a late upturn, the ASX 200 closed 0.38% in the red on Thursday. If you’re looking for blame, you can start with Donald J. Trump.
HD Capital Partners co-founder and co-CIO Harley Grosser reckons these three ASX small caps are ‘cheap’ with plenty of upside potential.
Original URL: https://www.couriermail.com.au/business/stockhead